Veterinary Trials Begin Clinical trials for GLP-1 use in dogs began in 2024, and preliminary results are promising
30 grams protein, 340 calories
This study will also have useful clinical implications in reducing the gut microbiota caused variation in the drug response among different populations
This technology protects the glutathione molecule from being destroyed by stomach acid, allowing it to reach the bloodstream intact
Integrating GLP-1 therapy into comprehensive care GLP-1 therapy is most effective when it is part of a structured program that also targets dietary habits, physical activity (including resistance training to preserve muscle mass), sleep, and stress management
However, the specificity of these criteria has recently been questioned [74]